Literature DB >> 3874607

Triggering infections in reactive arthritis.

V V Valtonen, M Leirisalo, P J Pentikäinen, T Räsänen, I Seppälä, U Larinkari, M Ranki, S Koskimies, M Malkamäki, P H Mäkelä.   

Abstract

Certain microbes like yersinia, salmonella, shigella, campylobacter, chlamydia, and possibly gonococcus can trigger reactive arthritis especially in patients of the HLA-B27 type. In the present study we have used serological and culture methods to identify the probable triggering infection in 50 consecutive HLA-B27 positive patients diagnosed as having reactive arthritis. The two most common triggering agents thus identified were Yersinia enterocolitica (12 patients) and Chlamydia trachomatis (11 patients). In addition six patients had high antistreptolysin O titres and two high teichoic acid antibody titres suggesting group A streptococci and Staphylococcus aureus as triggering agents. In 13 patients no preceding infection could be identified. The identity of the infective agent seems to have very little effect on the clinical picture of the reactive arthritis - the only difference between the various aetiological groups in the present material was absence of fever in the patients with a preceding C. trachomatis infection, of whom only one out of 11 had a temperature greater than or equal to 38 degrees C, whereas 13 of 16 patients with a preceding enterobacterial, and five of the eight patients with a streptococcal or staphylococcal infection had raised temperatures.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874607      PMCID: PMC1001660          DOI: 10.1136/ard.44.6.399

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Arthritis associated with Yersinia enterocolitica infection.

Authors:  P Ahvonen; K Sievers; K Aho
Journal:  Acta Rheumatol Scand       Date:  1969

2.  Reactive arthritis after campylobacter jejuni enteritis in patients with HLA-B27.

Authors:  T U Kosunen; O Kauranen; J Martio; T Pitkänen; A Pönkä; L Hortling; S Aittoniemi; O Mutru; O Penttilä; S Koskimies
Journal:  Lancet       Date:  1980-06-14       Impact factor: 79.321

3.  Reiter's syndrome associated with champylobacter fetus infection.

Authors:  J D Urman; R B Zurier; N F Rothfield
Journal:  Ann Intern Med       Date:  1977-04       Impact factor: 25.391

4.  Rheumatic fever. Clinical picture, differential diagnosis and sequels.

Authors:  M Leirisalo
Journal:  Ann Clin Res       Date:  1977

5.  Single-antigen immunofluorescence test for chlamydial antibodies.

Authors:  P Saikku; J Paavonen
Journal:  J Clin Microbiol       Date:  1978-08       Impact factor: 5.948

6.  Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27.

Authors:  M Leirisalo; G Skylv; M Kousa; L M Voipio-Pulkki; H Suoranta; M Nissilä; L Hvidman; E D Nielsen; A Svejgaard; A Tilikainen; O Laitinen
Journal:  Arthritis Rheum       Date:  1982-03

7.  The clinical features and HLA associations of reactive arthritis associated with non-gonococcal urethritis.

Authors:  A C Keat; R N Maini; G D Pegrum; J T Scott
Journal:  Q J Med       Date:  1979-04

8.  Assay of teichoic acid antibodies and antistaphylolysin in the diagnosis of Staphylococcal osteomyelitis.

Authors:  U Larinkari
Journal:  Scand J Infect Dis       Date:  1982

9.  Occurrence and specificity of antibodies against group-specific polysaccharides in beta-hemolytic streptococcal infections.

Authors:  I J Seppälä; U Larinkari; T Räsänen; V V Valtonen
Journal:  Acta Pathol Microbiol Scand B       Date:  1981-10

10.  Aseptic arthritis after gonorrhoea.

Authors:  L Rosenthal; B Olhagen; S Ek
Journal:  Ann Rheum Dis       Date:  1980-04       Impact factor: 19.103

View more
  17 in total

1.  Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts.

Authors:  G Kingsley; J Sieper
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

2.  Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis.

Authors:  T Yli-Kerttula; R Luukkainen; U Yli-Kerttula; T Möttönen; M Hakola; M Korpela; M Sanila; J Parviainen; J Uksila; R Vainionpää; A Toivanen
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

3.  Serology and bacteriology in reactive arthritis.

Authors:  C G van Bohemen; A J Nabbe; H C Zanen; H S Goei The
Journal:  Ann Rheum Dis       Date:  1986-03       Impact factor: 19.103

4.  Antibodies to arthritis-associated microbes in inflammatory joint diseases.

Authors:  O Mäki-Ikola; M K Viljanen; S Tiitinen; P Toivanen; K Granfors
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

5.  Staphylococcus aureus triggered reactive arthritis.

Authors:  A R Siam; M Hammoudeh
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

6.  Identification of the Yersinia enterocolitica urease beta subunit as a target antigen for human synovial T lymphocytes in reactive arthritis.

Authors:  P Probst; E Hermann; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

7.  Adult onset Still's disease and viral infections.

Authors:  J M Wouters; J van der Veen; L B van de Putte; D J de Rooij
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

8.  The value of specific antibody detection and culture in the diagnosis of reactive arthritis.

Authors:  J Sieper; J Braun; M Reichardt; U Eggens
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

9.  Association of various inflammatory diseases with human leukocyte antigens B27, B7, Bw4 and Bw6 in patients with SSA.

Authors:  Sangeeta Singh; Gyanendra K Sonkar; Usha Singh
Journal:  Rheumatol Int       Date:  2009-04-26       Impact factor: 2.631

10.  Various rheumatic syndromes in adult patients associated with high antistreptolysin O titres and their differential diagnosis with rheumatic fever.

Authors:  J M Valtonen; S Koskimies; A Miettinen; V V Valtonen
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.